Cibc Asset Management Inc Penumbra Inc Transaction History

Cibc Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$220.43 - $278.69 $5,290 - $6,688	24 Added 2.47%	994 $277,000
Q4 2022 Feb 13, 2023	SELL	$151.88 - $228.5 $64,852 - $97,569	-427 Reduced 30.57%	970 $215,000
Q3 2022 Nov 03, 2022	BUY	$120.36 - $205.88 $168,142 - $287,614	1,397 New	1,397 $265,000
Q2 2022 Aug 09, 2022	SELL	$116.09 - $227.33 $174,018 - $340,767	-1,499 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$238.08 - $288.0 $11,665 - $14,112	49 Added 3.38%	1,499 $431,000
Q3 2021 Nov 09, 2021	BUY	$250.72 - $291.24 $26,576 - $30,871	106 Added 7.89%	1,450 $386,000
Q1 2021 May 14, 2021	BUY	$175.6 - $291.43 $5,970 - $9,908	34 Added 2.6%	1,344 $364,000
Q3 2020 Nov 05, 2020	BUY	$185.27 - $238.73 $5,928 - $7,639	32 Added 2.5%	1,310 $255,000
Q4 2019 Feb 14, 2020	BUY	$134.81 - $177.8 $172,287 - $227,228	1,278 New	1,278 $210,000

383

29.6M

285K

168K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $7.26B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cibc Asset Management Inc with notifications on news.